Authors:
Moritz, S
Andresen, B
Jacobsen, D
Mersmann, K
Wilke, U
Lambert, M
Naber, D
Krausz, M
Citation: S. Moritz et al., Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics, EUR PSYCHIA, 16(6), 2001, pp. 354-361
Authors:
Naber, D
Moritz, S
Lambert, M
Rajonk, F
Holzbach, R
Mass, R
Andresen, B
Frank, P
Rudiger, H
Reinhard, M
Burghard, A
Citation: D. Naber et al., Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs, SCHIZOPHR R, 50(1-2), 2001, pp. 79-88
Authors:
Moritz, S
Mersmann, K
Kloss, M
Jacobsen, D
Andresen, B
Krausz, M
Pawlik, K
Naber, D
Citation: S. Moritz et al., Enhanced semantic priming in thought-disordered schizophrenic patients using a word pronunciation task, SCHIZOPHR R, 48(2-3), 2001, pp. 301-305
Authors:
Moritz, S
Lambert, M
Andresen, B
Bothern, A
Naber, D
Krausz, M
Citation: S. Moritz et al., Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients, COMP PSYCHI, 42(3), 2001, pp. 213-216
Authors:
Altamura, AC
Bobes, J
Owens, DC
Gerlach, J
Hellewell, JSE
Kasper, S
Naber, D
Tarrier, N
Van Os, J
Citation: Ac. Altamura et al., Schizophrenia: diagnosis and continuing treatment - principles of practicefrom the European expert panel on the contemporary treatment of schizophrenia, INT J PSYC, 4, 2000, pp. S1-S11
Authors:
Lambert, M
Haasen, C
Mass, R
Wagner, HB
Moritz, S
Krausz, M
Naber, D
Citation: M. Lambert et al., Correlation between consumption of psychotropic substances and suicidalityamong schizophrenics, NERVENHEILK, 19(2), 2000, pp. 69
Citation: Fg. Pajonk et al., Evaluation of efficacy of neuroleptics in open versus double-blind trials:objective, F NEUR PSYC, 68(7), 2000, pp. 313-320
Citation: M. Krausz et al., Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia, INT CLIN PS, 15(2), 2000, pp. 77-81
Authors:
Moritz, S
Krausz, M
Gottwalz, E
Lambert, M
Perro, C
Ganzer, S
Naber, D
Citation: S. Moritz et al., Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics, PSYCHOPATH, 33(1), 2000, pp. 48-51
Citation: M. Lambert et al., Conversion from conventional to atypical neuroleptics - recommendations for inpatient and outpatient treatment, NERVENARZT, 71(11), 2000, pp. 859
Authors:
Krausz, M
Moritz, SH
Naber, D
Lambert, M
Andresen, B
Citation: M. Krausz et al., Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia, EUR PSYCHIA, 14(2), 1999, pp. 84-88
Authors:
Moritz, S
Andresen, B
Domin, F
Martin, T
Probsthein, E
Kretschmer, G
Krausz, M
Naber, D
Spitzer, M
Citation: S. Moritz et al., Increased automatic spreading activation in healthy subjects with elevatedscores in a scale assessing schizophrenic language disturbances, PSYCHOL MED, 29(1), 1999, pp. 161-170